I don't claim to be a breeder, or even a great grower, but I can water a plant and I've always had an affinity for this one in particular.
Some years ago we decided to have some quantitative analysis performed by Cannalytics. It was a a very basic analysis only quantifying THC/CBD/CBN. I can't remember how many strains we had tested, but a lemon skunk and a hindu kush came back practically identical in terms of percentages and ratios. I concluded that this form of testing was absolutely worthless. These two plants couldn't be more dissimilar. The lemon is a nice stony indica with a heavy citrus fragrance (9-10 weeks tops) and the hk is more like a passable landrace that takes closer to 11 weeks with well rounded effects and very earthy tones. It's also important to note that we felt the hk would likely be the most different from the rest based on its effects prior to any testing. I had read up on Russo, so I was vaguely familiar with monoterpenes and such, but nobody was offering quantitative analysis in MI for them at that time.
Later Iron Labs started offering more complete profiles, and I needed to have oil tested for a particular patient to ensure that it was what it had been claimed to me to be (cannatonic 4), so I had complete profiles run on a few different things including the ls and hk again. The THC/CBD/CBN were very close to Cannalytics, but there was an additional 8% CBG identified in the hk. Initially, I was so caught up in the terpenes that I didn't really realize how high of a % of CBG that was. This was possibly due to my focus on the terpenes. I saw that the dominant terpene in ls was beta-myrcene, which seemed to make a lot of sense. For the hk I wasn't entirely sure if I could chalk the effects up to the dominant terpene which was alpha-Terpinine, or if I should attribute it to the CBG, or both. I felt like I needed a larger sample of data to weed through in order to make any heads or tails out of seeking desired effects through specific cannabinoids/terpenes. I couldn't search any site for terpenes (though there are a few not in MI that currently have this feature), but I felt that collectively shared data could put the community on pace with the likes of GW, and beyond. Unfortunately, I couldn't get anyone to play along so I put it on the back burner. The fact that I'm over 5 hours from the bridge doesn't help as far as getting my samples run. I'm a one man show and I recently had my first child so over the past few years I've seen my level of free time rapidly diminish. Plus I'm anti-social as fuck. Anyway, I think it was towards the end of last year when I saw some stories about subcool or somebody working on developing CBG strains citing 1.5-2% as being a high % that I fully realized what I may have stumbled across.
This cut is of unknown origins. I got it from a super shady hole in the wall retail store in Lansing on my way back from a show in GR shortly after the law went into effect. I have no idea if anyone else is in possession of it. If they are they haven't had it tested (though another hk was recently tested at 3% in MI).
I've been spending the last year looking for new keepers to bring in, so I haven't run the hk in a while, but it's next in line to go into a room that has a ways to go. I'll document it here. I have a sample on hand from a buddy of mine who didn't pull off his best round. I'll post the results of that sample as well as the table from my room when it's done.
Assuming it's not a fluke I'll self it and cross it with other keepers to see if the trait is passed on.
Here is the profile:
Here's the tip of the iceberg in terms of medicinal benefits (a patient with bowel issues has used this cut for years):
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid
Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells
Neuroprotective properties of cannabigerol in Huntington's disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice
Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol.
Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol
Evidence that the plant cannabinoid cannabigerol is a highly potent α2‐adrenoceptor agonist and moderately potent 5HT1A receptor antagonist
Some years ago we decided to have some quantitative analysis performed by Cannalytics. It was a a very basic analysis only quantifying THC/CBD/CBN. I can't remember how many strains we had tested, but a lemon skunk and a hindu kush came back practically identical in terms of percentages and ratios. I concluded that this form of testing was absolutely worthless. These two plants couldn't be more dissimilar. The lemon is a nice stony indica with a heavy citrus fragrance (9-10 weeks tops) and the hk is more like a passable landrace that takes closer to 11 weeks with well rounded effects and very earthy tones. It's also important to note that we felt the hk would likely be the most different from the rest based on its effects prior to any testing. I had read up on Russo, so I was vaguely familiar with monoterpenes and such, but nobody was offering quantitative analysis in MI for them at that time.
Later Iron Labs started offering more complete profiles, and I needed to have oil tested for a particular patient to ensure that it was what it had been claimed to me to be (cannatonic 4), so I had complete profiles run on a few different things including the ls and hk again. The THC/CBD/CBN were very close to Cannalytics, but there was an additional 8% CBG identified in the hk. Initially, I was so caught up in the terpenes that I didn't really realize how high of a % of CBG that was. This was possibly due to my focus on the terpenes. I saw that the dominant terpene in ls was beta-myrcene, which seemed to make a lot of sense. For the hk I wasn't entirely sure if I could chalk the effects up to the dominant terpene which was alpha-Terpinine, or if I should attribute it to the CBG, or both. I felt like I needed a larger sample of data to weed through in order to make any heads or tails out of seeking desired effects through specific cannabinoids/terpenes. I couldn't search any site for terpenes (though there are a few not in MI that currently have this feature), but I felt that collectively shared data could put the community on pace with the likes of GW, and beyond. Unfortunately, I couldn't get anyone to play along so I put it on the back burner. The fact that I'm over 5 hours from the bridge doesn't help as far as getting my samples run. I'm a one man show and I recently had my first child so over the past few years I've seen my level of free time rapidly diminish. Plus I'm anti-social as fuck. Anyway, I think it was towards the end of last year when I saw some stories about subcool or somebody working on developing CBG strains citing 1.5-2% as being a high % that I fully realized what I may have stumbled across.
This cut is of unknown origins. I got it from a super shady hole in the wall retail store in Lansing on my way back from a show in GR shortly after the law went into effect. I have no idea if anyone else is in possession of it. If they are they haven't had it tested (though another hk was recently tested at 3% in MI).
I've been spending the last year looking for new keepers to bring in, so I haven't run the hk in a while, but it's next in line to go into a room that has a ways to go. I'll document it here. I have a sample on hand from a buddy of mine who didn't pull off his best round. I'll post the results of that sample as well as the table from my room when it's done.
Assuming it's not a fluke I'll self it and cross it with other keepers to see if the trait is passed on.
Here is the profile:
Here's the tip of the iceberg in terms of medicinal benefits (a patient with bowel issues has used this cut for years):
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid
Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells
Neuroprotective properties of cannabigerol in Huntington's disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice
Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol.
Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol
Evidence that the plant cannabinoid cannabigerol is a highly potent α2‐adrenoceptor agonist and moderately potent 5HT1A receptor antagonist